Hematology and coagulation preanalytics for clinical chemists: Factors intrinsic to the sample and extrinsic to the patient

被引:2
|
作者
Winter, William E. [1 ]
Pittman, David L. [2 ]
Harris, Neil S. [1 ]
机构
[1] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[2] Univ Florida, Endocrine Autoantibody Lab, Hlth Pathol Labs, Gainesville, FL 32608 USA
关键词
PNEUMATIC TUBE SYSTEM; PARTIAL THROMBOPLASTIN TIME; BLOOD-CELL COUNT; PROTHROMBIN TIME; ROUTINE HEMATOLOGY; DRAW; TRANSPORT; HEMOLYSIS; STABILITY; SPECIMENS;
D O I
10.1016/j.clinbiochem.2022.11.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In hematology and coagulation, diligence in the preanalytical phase of testing is of critical importance to obtaining reliable test results. If the sample used for testing is unsuitable, even outstanding analytical procedures and technology cannot produce a clinically-reliable result. Therefore, the intent of this manuscript is to review preanalytical factors intrinsic to the sample that affect the hematology and coagulation testing. Factors intrinsic to the sample (excluding in vivo anomalies) can be controlled, theoretically, by phlebotomists (including nurses) and laboratorians in the preanalytical phase of testing. Furthermore, the management and prevention of such factors is highlighted. Erroneous control of preanalytical factors can produce laboratory errors.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 25 条
  • [21] Cannabis use is associated with patient and clinical factors in a population-based sample of colorectal cancer survivors
    Newcomb, P. A.
    Ton, M.
    Malen, R. C.
    Heffner, J. L.
    Labadie, J.
    Phipps, A., I
    Burnett-Hartman, A. N.
    CANCER CAUSES & CONTROL, 2021, 32 (12) : 1321 - 1327
  • [22] Cannabis use is associated with patient and clinical factors in a population-based sample of colorectal cancer survivors
    P. A. Newcomb
    M. Ton
    R. C. Malen
    J. L. Heffner
    J. Labadie
    A. I. Phipps
    A. N. Burnett-Hartman
    Cancer Causes & Control, 2021, 32 : 1321 - 1327
  • [23] Doses Evaluated in Clinical Pharmacology Studies Investigating the Effect of Intrinsic and Extrinsic Factors on PK and Safety: Case Examples from Approved Drug Development Programs
    Kaspera, Rudiger
    Shitara, Yoshihisa
    AAPS JOURNAL, 2024, 26 (04):
  • [24] Association of coagulation factors profile with clinical outcome in patient with COVID-19 and acute stroke: A second wave cohort study
    Rasyid, Al
    Riyanto, Dinda Larastika
    Harris, Salim
    Kurniawan, Mohammad
    Mesiano, Taufik
    Hidayat, Rakhmad
    Wiyarta, Elvan
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2022, 82 (04) : 371 - 377
  • [25] Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications
    Voicu, S.
    Delrue, M.
    Chousterman, B. G.
    Stepanian, A.
    Bonnin, P.
    Malissini, I
    Deye, N.
    Neuwirth, M.
    Ketfi, C.
    Mebazaa, A.
    Siguret, V
    Megarbane, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (17) : 9161 - 9168